ACADIA Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0042251084
USD
22.54
0.38 (1.71%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,071.51
957.80
726.44
517.24
484.14
441.75
339.08
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,071.51
957.80
726.44
517.24
484.14
441.75
339.08
Raw Material Cost
99.89
96.80
45.73
10.17
11.95
11.69
11.34
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
538.00
473.46
402.47
369.09
403.22
397.52
333.89
Other Expenses
32.88
30.32
35.16
36.16
23.94
26.63
24.04
Total Expenditure (Excl Depreciation)
966.69
873.52
799.82
740.83
654.58
675.54
585.62
Operating Profit (PBDIT) excl Other Income
104.80000000000001
84.3
-73.4
-223.6
-170.39999999999998
-233.79999999999998
-246.5
Other Income
34.09
173.80
22.34
10.15
2.92
5.61
12.16
Operating Profit (PBDIT)
150.66
273.96
-45.48
-211.42
-164.18
-225.24
-231.62
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
-52.80
0.00
Gross Profit (PBDT)
971.62
860.99
680.71
507.07
472.19
430.07
327.73
Depreciation
11.76
15.88
5.55
2.03
3.34
2.93
2.77
Profit Before Tax
138.90
258.07
-51.04
-213.44
-167.52
-280.97
-234.38
Tax
-252.10
31.62
10.25
2.53
0.35
0.61
0.88
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
391.00
226.45
-61.29
-215.97
-167.87
-281.58
-235.26
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
391.00
226.45
-61.29
-215.97
-167.87
-281.58
-235.26
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
391.00
226.45
-61.29
-215.97
-167.87
-281.58
-235.26
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,227.39
732.79
431.75
400.41
540.89
627.01
699.13
Earnings per share (EPS)
2.3
1.36
-0.37
-1.34
-1.05
-1.79
-1.6
Diluted Earnings per share
2.3
1.36
-0.37
-1.34
-1.05
-1.79
-1.6
Operating Profit Margin (Excl OI)
9.78%
8.8%
-10.1%
-43.23%
-35.2%
-52.92%
-72.71%
Gross Profit Margin
14.06%
28.6%
-6.26%
-40.87%
-33.91%
-62.94%
-68.31%
PAT Margin
36.49%
23.64%
-8.44%
-41.76%
-34.67%
-63.74%
-69.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 11.87% vs 31.86% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 72.63% vs 469.49% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 16.37% vs 247.79% in Dec 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of ACADIA Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,071.51
606.42
465.09
76.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,071.51
606.42
465.09
76.69%
Raw Material Cost
99.89
128.94
-29.05
-22.53%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
83.80
-83.80
-100.00%
Selling and Distribution Expenses
538.00
701.17
-163.17
-23.27%
Other Expenses
32.88
68.73
-35.85
-52.16%
Total Expenditure (Excl Depreciation)
966.69
1,601.20
-634.51
-39.63%
Operating Profit (PBDIT) excl Other Income
104.81
-994.78
1,099.59
110.54%
Other Income
34.09
58.81
-24.72
-42.03%
Operating Profit (PBDIT)
150.66
-919.51
1,070.17
116.38%
Interest
0.00
83.80
-83.80
-100.00%
Exceptional Items
0.00
-251.99
251.99
100.00%
Gross Profit (PBDT)
971.62
477.48
494.14
103.49%
Depreciation
11.76
16.45
-4.69
-28.51%
Profit Before Tax
138.90
-1,271.75
1,410.65
110.92%
Tax
-252.10
5.03
-257.13
-5,111.93%
Provisions and contingencies
0
0
0.00
Profit After Tax
391.00
-1,276.78
1,667.78
130.62%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
391.00
-1,276.78
1,667.78
130.62%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
391.00
-1,276.78
1,667.78
130.62%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
1,227.39
738.98
488.41
66.09%
Earnings per share (EPS)
2.30
-6.42
8.72
135.83%
Diluted Earnings per share
2.30
-6.42
8.72
135.83%
Operating Profit Margin (Excl OI)
9.78%
-164.04%
0.00
173.82%
Gross Profit Margin
14.06%
-207.00%
0.00
221.06%
PAT Margin
36.49%
-210.54%
0.00
247.03%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 107.15 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 11.87% vs 31.86% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 39.10 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 72.63% vs 469.49% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.66 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 16.37% vs 247.79% in Dec 2024

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.78%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024